Mesothelioma Lawyers Blog
The prognosis for mesothelioma sufferers is grave. Most sufferers do not have a very long life expectancy. While experimental treatments always raise hope for patients and their loved ones, it is difficult to know when these scientific breakthroughs can deliver practical and positive results for patients. Another new treatment is offering hope to the victims of the deadly cancer and has been making headlines worldwide.
Asbestos-related cancer, also known as mesothelioma, is problematic in industrialized nations throughout the world. Scientific communities throughout the U.K., Europe, Australia, Asia, and the United States have been working for a treatment and cure of the fatal cancer. According to the Asbestos Diseases Research Institute in Sydney, new research results could signal a breakthrough genetic treatment. Our mesothelioma attorneys in New England are abreast of all medical and legal issues related to mesothelioma. We are dedicated to providing legal support to clients and staying abreast of developments in the medical community.
New results published in the International Journal Oncology indicate that the new treatment uses bacterial cells to carry micro RNA into the tumors. These mini cells have no genetic information and are protected with anti-bodies that insulate them as they are delivered to the target cells. Scientists vested in this new research claim that the mini cells are slowing the growth and development of new cancer cells in animals. According to researchers, the experiment, which lasted a month in duration, led to the reduction in tumor size. The tumors also did not expand after the genetic treatment.
Scientists explain that the low levels of micro RNA in mesothelioma cells could be contributing to the very quick and rapid development of the cancer. As patients know, exposure to asbestos which causes mesothelioma results in fatality. While patients may not be diagnosed for years or decades, any diagnosis of the disease will likely prove fatal. This is one treatment that could potentially reduce the size of mesothelioma tumors or at least stop them from growing. Scientists found that the tumor size and growth was greatly repressed after receiving the mini cells.
The discovery that micro RNA can inhibit tumors could also expand the treatment of other kinds of cancers, increase longevity for cancer patients, and improve treatment options. Individuals who have been diagnosed with mesothelioma are usually given a life expectancy for one year. Current treatments for the disease can only expand life expectancy to 15 months. Researchers for the institute will be recruiting mesothelioma patients to start early stage clinical trials in the next six weeks. The institute is raising hope for victims in Australia, where mesothelioma has killed more than 10,000 since the early 1980”s. In the next four decades, another 25,000 are expected to die from the disease.
The testing process for new drugs can take years. The clinical trials will assess the action of treatment on the body. This process takes place before the institute will assess safety and dosage for patients. Still, the study is raising hope and could lead to a successful treatment in combating the growth of cancer cells.
If you or a loved one is diagnosed with mesothelioma, call for a free and confidential appointment at (617) 777-7777.
More Blog Entries:
Sequester Hits Mesothelioma Research, Dec. 10, 2013, Boston Mesothelioma Lawyer Blog
Lawmakers Try to Limit the Rights of Asbestos Victims, Dec. 4, 2013, Boston Mesothelioma Lawyer Blog